January 07, 2013 at 12:16 PM EST
UPDATE: Piper Jaffray Reiterates Neutral Rating, Raises PT on Sequenom
In a report published Monday, Piper Jaffray & Co. reiterated its Neutral rating on Sequenom (NASDAQ: SQNM ), and slightly raised its price target from $4.50 to $5.00. Piper Jaffray noted, “Sequenom announced positive preliminary 2012 results, with revenue increasing ~59% year-over-year, implying 4Q12 revenue of ~$33M, favorable to both
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here